Back to search
FDAFDA · Food and drugs·Recall number D-0784-2021

Donepezil HCL Tablets, USP, 5 mg, 90-count bottle, Rx only, Manufactured by: Jubilant Generics Ltd. India, Marketed by: Jubilant Cadista Pharmaceuticals Inc. Salisbury, MD 21801 NDC 59746-329-90

Published September 8, 2021 · Recall initiated: August 20, 2021

Summary

FDA records drug Class III recall D-0784-2021, published September 8, 2021 and initiated August 20, 2021. Recalling firm: Jubilant Cadista Pharmaceuticals, Inc.; Status: Terminated; Reported quantity: 14,544 bottles; Lot: Lot # DN120006A, exp. date 12/2021. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Subpotent

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Jubilant Cadista Pharmaceuticals, Inc.
Distributor
Product was distributed nationwide.
Lot
Lot # DN120006A, exp. date 12/2021
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Donepezil HCL Tablets, USP, 5 mg, 90-count bottle, Rx only, Manufactured by: Jubilant Generics Ltd. India, Marketed by: Jubilant Cadista Pharmaceuticals Inc. Salisbury, MD 21801 NDC 59746-329-90 recalled?

Yes. FDA published recall D-0784-2021 on September 8, 2021. Reported hazard: Subpotent

What should I do if I have this product?

Voluntary: Firm initiated · Letter